The Vegas Comic Kingdom
Eddie Brock: Carnage #7 J. Scott Campbell Just Spectacular Collection Variant (Marvel Comics, 2025) (NM/NM+)
Eddie Brock: Carnage #7 J. Scott Campbell Just Spectacular Collection Variant (Marvel Comics, 2025) (NM/NM+)
Low stock: 1 left
Regular price
$8.00 USD
Regular price
Sale price
$8.00 USD
Unit price
per
Shipping calculated at checkout.
Couldn't load pickup availability
Eddie Brock: Carnage #7 J. Scott Campbell Just Spectacular Collection Variant (Marvel Comics, 2025)Unleash the chaos with Eddie Brock: Carnage #7 J. Scott Campbell Just Spectacular Collection Variant, a thrilling collectible from VegasComics.com! Released August 13, 2025, this 32-page issue, written by Charles Soule and illustrated by Jesus Saiz, features key appearances by Eddie Brock, Carnage, and Muse, the twisted serial killer. Titled “Like an Itch You Just Can’t Scratch,” Eddie grapples with Carnage’s overwhelming bloodlust, haunted by dreams of a mysterious woman and a green phoenix. As his health and willpower fade, Eddie faces a moral dilemma: will he kill an innocent or find a deserving target for Carnage’s wrath? Campbell’s dynamic cover amplifies the issue’s intensity.Current Fair Market Value: Retailing at $3.99 (UPC: 75960621053400721), this variant is listed at $3.99-$5.99 on eBay, Golden Apple Comics, and Midtown Comics, with NM copies averaging $5-$7 due to Campbell’s iconic art and fan demand.
Projected Fair Market Value: This variant could reach $10-$18 in 12-18 months for high-grade copies (9.8 CGC), driven by the series’ critical acclaim (8.0/10 critic rating), Muse’s return, and Campbell’s collectible appeal. Potential MCU tie-ins, like Venom 3 buzz, could push values to $20-$30, though standard variant status may cap short-term spikes.
Investment Highlights: Campbell’s vibrant cover, Muse’s chilling presence, and Eddie’s moral struggle make this a must-have for symbiote fans. The series’ gory narrative and strong creative team enhance its draw. Secure this electrifying variant at VegasComics.com to invest in Carnage’s bloody 2025 saga
